Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-018959
Filing Date
2022-12-23
Accepted
2022-12-23 09:23:19
Documents
8
Period of Report
2023-01-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230124xdef14a.htm DEF 14A 756945
2 GRAPHIC tmb-20230124xdef14a002.jpg GRAPHIC 3530
3 GRAPHIC tmb-20230124xdef14a018.jpg GRAPHIC 172215
4 GRAPHIC tmb-20230124xdef14a003.jpg GRAPHIC 5683
5 GRAPHIC tmb-20230124xdef14a001.jpg GRAPHIC 7149
6 GRAPHIC tmb-20230124xdef14a004.jpg GRAPHIC 7242
7 GRAPHIC tmb-20230124xdef14a019.jpg GRAPHIC 152489
8 GRAPHIC tmb-20230124xdef14a008.jpg GRAPHIC 24657
  Complete submission text file 0001558370-22-018959.txt   1272664
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38520 | Film No.: 221483543
SIC: 2836 Biological Products, (No Diagnostic Substances)